Outstanding Benefits for Patients

Breast Cancer

  • 39 years old
  • Female patient
  • Cancer had persisted after 5 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Breast Cancer

  • 53 years old
  • Female patient
  • Cancer had persisted after 10 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Ovarian Cancer

  • 48 years old
  • Female patient
  • Cancer had persisted after 3 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Neuroendocrine Tumor of Cervix

  • 41 years old
  • Female patient
  • Cancer had persisted after 4 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Gallbladder Cancer

  • 32 years old
  • Female patient
  • Cancer had persisted after 2 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Leiomyosarcoma

  • 53 years old
  • Female patient
  • Cancer had persisted after 2 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Melanoma

  • 46 years old
  • Female patient
  • Cancer had persisted after 5 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Lung Cancer

  • 62 years old
  • Male patient
  • Cancer had persisted after 4 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Head and Neck Cancer

  • 42 years old
  • Male patient
  • Cancer had persisted after 5 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Head and Neck Cancer

  • 51 years old
  • Male patient
  • Cancer had persisted after 3 lines of therapy

Before

Resilient Protocol with Exacta Analysis

After Treatment

Head and Neck Cancer

  • 65 years old
  • Female patient
  • Cancer had persisted after 3 lines of therapy

Day 0

Day 30

Day 79

CONTACT US

Please contact us for more details.

Please fill in the contact inquiry form below. We will get back to you shortly by email. Thank you!

I have read and understood the terms of use and the privacy policy and I agree.